387447004: Reserpine (substance)

SNOMED CT Concept\Substance\...

\Drug or medicament (substance)\agent cardiovasculaire\Hypotensive agent (substance)\Rauwolfia alkaloid (substance)\Reserpine

\Substance categorised by structure\Chemical\Chemical categorized by structure\Organic compound\Organic cyclic compound\Heterocyclic compound (substance)\Alkaloid (substance)\Naturally occurring alkaloid (substance)\Plant alkaloid\Rauwolfia alkaloid (substance)\Reserpine

\Substance categorized functionally\Phytochemical\Plant alkaloid\Rauwolfia alkaloid (substance)\Reserpine

\Material (substance)\Natural material\Organic natural material\Plant material (substance)\...

\Phytochemical\Plant alkaloid\Rauwolfia alkaloid (substance)\Reserpine

\Plant agent (substance)\Plant alkaloid\Rauwolfia alkaloid (substance)\Reserpine

\Biological substance\Organic natural material\Plant material (substance)\...

\Phytochemical\Plant alkaloid\Rauwolfia alkaloid (substance)\Reserpine

\Plant agent (substance)\Plant alkaloid\Rauwolfia alkaloid (substance)\Reserpine

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Reserpine	Is a	Rauwolfia alkaloid (substance)	true	Inferred relationship	Existential restriction modifier (core metadata concept)

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Resperine measurement	Component	True	Reserpine	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Poisoning by reserpine	Causative agent (attribute)	False	Reserpine	Inferred relationship	Existential restriction modifier (core metadata concept)
Reserpine 100%	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Reserpine	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing reserpine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Reserpine	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Reserpine poisoning	Causative agent (attribute)	True	Reserpine	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely chlorothiazide 250 milligram and reserpine 125 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Reserpine	Inferred relationship	Existential restriction modifier (core metadata concept)
Chlorothiazide 500 mg and reserpine 125 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Reserpine	Inferred relationship	Existential restriction modifier (core metadata concept)
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Reserpine	Inferred relationship	Existential restriction modifier (core metadata concept)
Hydrochlorothiazide 25 mg and reserpine 125 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Reserpine	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely hydrochlorothiazide 50 milligram and reserpine 125 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Reserpine	Inferred relationship	Existential restriction modifier (core metadata concept)
Methyclothiazide 2.5 mg and reserpine 100 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Reserpine	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing chlorothiazide and reserpine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Reserpine	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing hydrochlorothiazide and reserpine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Reserpine	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing hydralazine hydrochloride and hydrochlorothiazide and reserpine	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Reserpine	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing methyclothiazide and reserpine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Reserpine	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Adverse reaction to reserpine	Causative agent (attribute)	True	Reserpine	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely chlorothiazide 250 milligram and reserpine 125 microgram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	False	Reserpine	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Chlorothiazide 500 mg and reserpine 125 microgram oral tablet	Has basis of strength substance (attribute)	True	Reserpine	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Reserpine	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet	Has basis of strength substance (attribute)	True	Reserpine	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Methyclothiazide 2.5 mg and reserpine 100 microgram oral tablet	Has basis of strength substance (attribute)	True	Reserpine	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Chlorothiazide 500 mg and reserpine 125 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Reserpine	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Chlorothiazide 500 mg and reserpine 125 microgram oral tablet	Has basis of strength substance (attribute)	False	Reserpine	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet	Has basis of strength substance (attribute)	False	Reserpine	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Hydrochlorothiazide 25 mg and reserpine 125 microgram oral tablet	Has basis of strength substance (attribute)	True	Reserpine	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely hydrochlorothiazide 50 milligram and reserpine 125 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Reserpine	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely hydrochlorothiazide 50 milligram and reserpine 125 microgram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	False	Reserpine	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Methyclothiazide 2.5 mg and reserpine 100 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Reserpine	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Methyclothiazide 2.5 mg and reserpine 100 microgram oral tablet	Has basis of strength substance (attribute)	False	Reserpine	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Hydrochlorothiazide 25 mg and reserpine 125 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Reserpine	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Hydrochlorothiazide 25 mg and reserpine 125 microgram oral tablet	Has basis of strength substance (attribute)	False	Reserpine	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely hydrochlorothiazide 50 milligram and reserpine 125 microgram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	True	Reserpine	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely chlorothiazide 250 milligram and reserpine 125 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Reserpine	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely chlorothiazide 250 milligram and reserpine 125 microgram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	True	Reserpine	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely chlorothiazide 250 milligram and reserpine 125 microgram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	False	Reserpine	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Chlorothiazide 500 mg and reserpine 125 microgram oral tablet	Has precise active ingredient	True	Reserpine	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing chlorothiazide and reserpine in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Reserpine	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Hydrochlorothiazide 25 mg and reserpine 125 microgram oral tablet	Has precise active ingredient	True	Reserpine	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely hydrochlorothiazide 50 milligram and reserpine 125 microgram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	True	Reserpine	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Methyclothiazide 2.5 mg and reserpine 100 microgram oral tablet	Has precise active ingredient	True	Reserpine	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet	Has precise active ingredient	False	Reserpine	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Hydralazine- and hydrochlorothiazide- and reserpine-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Reserpine	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing methyclothiazide and reserpine in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Reserpine	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing hydrochlorothiazide and reserpine in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Reserpine	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Hydralazine- and hydrochlorothiazide- and reserpine-containing product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Reserpine	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing only chlorothiazide and reserpine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Reserpine	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing only hydrochlorothiazide and reserpine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Reserpine	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Methyclothiazide and reserpine only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Reserpine	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Hydralazine and hydrochlorothiazide and reserpine only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Reserpine	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing only reserpine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Reserpine	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing only chlorothiazide and reserpine in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Reserpine	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Methyclothiazide and reserpine only product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Reserpine	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Hydralazine and hydrochlorothiazide and reserpine only product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Reserpine	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing only hydrochlorothiazide and reserpine in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Reserpine	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely chlorothiazide 250 milligram and reserpine 125 microgram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	True	Reserpine	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet	Has precise active ingredient	True	Reserpine	Inferred relationship	Existential restriction modifier (core metadata concept)	2

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1461625016	Reserpine (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1481538014	Reserpine	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1461625016	Reserpine (substance)	en	Fully specified name	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
1461625016	Reserpine (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1481538014	Reserpine	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
1481538014	Reserpine	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
368071000195110	reserpina	it	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
837851000172114	réserpine	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
837851000172114	réserpine	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
368071000195110	reserpina	it	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module